One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1002/ajh.26847
Copy DOI
Export
Save
Share
Cite Journal: American Journal of Hematology |  Publication Date: Feb 6, 2023 |
 Citations: 5 |  License type: CC BY-NC-ND 4.0 |
Affiliation: Royal Melbourne Hospital, The Alfred Hospital, Monash University, Samsung (South Korea), Bristol-Myers Squibb (United States), Cornell University, NewYork–Presbyterian Hospital, University Hospital Ulm, The University of Texas MD Anderson Cancer Center, Indiana University, AZ Sint-Jan, University of Kansas, University of Helsinki, Hospital Universitari i Politècnic La Fe, Assistance Publique – Hôpitaux de Paris, Université Paris Cité
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
